NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Exactly. Very expensive, serious side effects that also may need treatment and often not effective for all patients or even the majority in various areas of cancer. Yet it is a very important drug and insurance generally covers it. I am sure the insurance companies may negotiate their rates as well, to some degree. But it is still very expensive. DCVax-L, I believe, will be provided in a community setting. It has virtually no significant side-effects and a substantial number of patients have a significant benefit from it. Add poly-iclc and we might get arms like the one in the yet to be published in a peer review article, where 4 out of 4 are still living, 1 over 9’years and 3 over 10 years.